---
title: Macrocyclics, Inc. vs Sussex Research Laboratories Inc.
slug_a: macrocyclics
slug_b: sussex-research
site: cdmo
review_signal_gate: closed
canonical_path: /compare/macrocyclics/sussex-research
generated_by: BioBM Editorial AI
---

# Macrocyclics, Inc. vs Sussex Research Laboratories Inc.

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Macrocyclics, Inc. (macrocyclics) is listed for cdmo. Chelator-focused CDMO for radiopharmaceuticals, offering cGMP clinical-trial manufacture, custom synthesis scaled to kilogram quantities, bioconjugation, and HPLC/Q-TOF analytical testing.

Services: 5. Modalities: 3. Indications: 1. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (5).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Sussex Research Laboratories Inc. (sussex-research) is listed for both. Global leader in carbohydrate and glycan synthesis, offering custom synthesis, CRO, and CDMO services for drug discovery and development. Specializes in GalNAc targeting ligands, glycopeptides, and glycoconjugates with over 25 years of expertise.

Services: 9. Modalities: 4. Indications: 3. Locations: 1. Certifications: 1. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (9).

Review summary: Review summary withheld until site-level review gate opens.